Indigo Acquisition (INAC) EBITDA (2025 - 2026)
Indigo Acquisition's (INAC) quarterly EBITDA came in at -$162375.0 in Q1 2026, down 527.66% YoY from $37968.5 in Q1 2025, and down 28.22% on a QoQ basis from -$126636.0 in Q4 2025.
Powered by 
Analysis
Indigo Acquisition (INAC) EBITDA (2025 - 2026) Analysis & Trends
Indigo Acquisition (INAC) has 2 years of EBITDA data on file, last reported at -$162375.0 in Q1 2026.
- Quarterly EBITDA fell 527.66% year-over-year to -$162375.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$504501.0 (changed N/A YoY) and the FY2025 annual result came in at -$367996.0, down 1869.79% from the prior year.
- EBITDA eased to -$162375.0 in Q1 2026, from -$126636.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$25870.0 in Q1 2025 to a low of -$162375.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -8,222.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | -503,862.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | -808,001.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | -167,765.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | -150,114.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | -112,227.00 |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | -1.01 Mn |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | -593,448.00 |
| 10 | Indigo Acquisition | 152.12 Mn | 152.12 Mn | - | -120,605.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120,605.00 |
| Mar 31, 2026 | -162,375.00 |
| Dec 31, 2025 | -126,636.00 |
| Sep 30, 2025 | -152,601.00 |
| Jun 30, 2025 | -62,889.00 |
| Mar 31, 2025 | -25,870.00 |